menu
    • menu

    Company profile for Kriya Therapeutics

    NEW Drugs in Dev: 4
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kriya is a next-generation gene therapy company focused on designing and developing transformative new treatments for highly prevalent and severe chronic diseases. We target conditions where the underlying biology is well-understood, rationally designing one-time gene therapies to durably express therapeutic proteins within the appropriate human tissues. Our team has deep expertise in the field and includes former senior leade...
    Kriya is a next-generation gene therapy company focused on designing and developing transformative new treatments for highly prevalent and severe chronic diseases. We target conditions where the underlying biology is well-understood, rationally designing one-time gene therapies to durably express therapeutic proteins within the appropriate human tissues. Our team has deep expertise in the field and includes former senior leadership from pioneering gene therapy companies and academic institutions. We use algorithmic tools, scalable infrastructure, and proprietary technology to optimize the efficacy and durability of our gene therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kriya TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3000 El Camino Real, Building 4, Suite 200 Palo Alto, CA 94306
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kriyatherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kriyatherapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kriya Showcases Gene Therapy Progress At ASGCT 2026
    Kriya Showcases Gene Therapy Progress At ASGCT 2026

    30 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/30/3284841/0/en/kriya-announces-presentations-at-asgct-2026-highlighting-advances-across-gene-therapy-platform.html

    GLOBENEWSWIRE
    30 Apr 2026
    Share Share
    Kriya Appoints Sachiyo Minegishi As Chief Financial Officer
    Kriya Appoints Sachiyo Minegishi As Chief Financial Officer

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212750/0/en/Kriya-Appoints-Sachiyo-Minegishi-as-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Kriya Appoints Greg Di Russo, MD As Chief Medical Officer
    Kriya Appoints Greg Di Russo, MD As Chief Medical Officer

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3197108/0/en/Kriya-appoints-Greg-Di-Russo-MD-as-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Kriya Secures $320M Series D for Chronic Disease Gene Therapies
    Kriya Secures $320M Series D for Chronic Disease Gene Therapies

    10 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/10/3147697/0/en/Kriya-Announces-320-Million-Series-D-Financing-to-Advance-Pipeline-of-Gene-Therapies-for-Chronic-Diseases-of-High-Unmet-Need.html

    GLOBENEWSWIRE
    10 Sep 2025
    Share Share
    Gene Therapy Specialist Kriya Raises $313M
    Gene Therapy Specialist Kriya Raises $313M

    18 Aug 2025

    // BIOSPACE

    https://www.biospace.com/business/gene-therapy-specialist-kriya-raises-313m

    BIOSPACE
    18 Aug 2025
    Share Share
    Kriya Presents Data at 2025 ARVO Annual Meeting
    Kriya Presents Data at 2025 ARVO Annual Meeting

    08 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/08/3077485/0/en/Kriya-Presents-Data-at-the-2025-Association-for-Research-in-Vision-and-Ophthalmology-ARVO-Annual-Meeting.html

    GLOBENEWSWIRE
    08 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search